BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Immunoglobulin Switch Region

Below is an extended Immunoglobulin Switch Region patents listing. Click here to return to the Immunoglobulin Switch Region main in depth entry.

Patents :

US Patent No.Title
5545806 Ransgenic non-human animals for producing heterologous antibodies
6312694 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
6323185 Anti-viral guanosine-rich oligonucleotides and method of treating HIV
6342219 Antibody compositions for selectively inhibiting VEGF
6342221 Antibody conjugate compositions for selectively inhibiting VEGF
6355785 Guanosine-rich oligonucleotide integrase inhibitors
6395515 Directed switch-mediated DNA recombination
6406693 Cancer treatment methods using antibodies to aminophospholipids
6416758 Antibody conjugate kits for selectively inhibiting VEGF
6455250 Endonuclease compositions and methods of use
6482411 Methods of reducing bone loss with CD40 ligand
6300129 Transgenic non-human animals for producing heterologous antibodies
6288042 Anti-viral guanosine-rich tetrad forming oligonucleotides
5569825 Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
5625126 Transgenic non-human animals for producing heterologous antibodies
5661016 Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
5714352 Directed switch-mediated DNA recombination
5770429 Transgenic non-human animals capable of producing heterologous antibodies
5789650 Transgenic non-human animals for producing heterologous antibodies
5814318 Transgenic non-human animals for producing heterologous antibodies
5877397 Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
5985615 Directed switch-mediated DNA recombination
6255458 High affinity human antibodies and human antibodies against digoxin
6524583 Antibody methods for selectively inhibiting VEGF
6676941 Antibody conjugate formulations for selectively inhibiting VEGF
6680209 Human antibodies as diagnostic reagents
7189515 Human antibodies as detection reagents
7192582 Human monoclonal antibodies to FC alpha receptor (CD89)
7247301 Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
7247303 Selected antibody CDRs for binding to aminophospholipids
7247304 Methods of treating using anti-IL-15 antibodies
7282568 Human monoclonal antibodies against interleukin 8 (IL-8)
7314926 Antiproliferative activity of g-rich oligonucleotides and method of using same to bind to nucleolin
7329405 Human antibodies specific for interleukin 15 (IL-15)
7378386 Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives
7384909 Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents
7153507 Human antibodies specific for interleukin 15 (IL-15)
7135287 Human antibodies
6703020 Antibody conjugate methods for selectively inhibiting VEGF
6783760 Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
6794132 Human antibodies
6818213 Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
6887468 Antibody kits for selectively inhibiting VEGF
6984720 Human CTLA-4 antibodies
7041871 Transgenic non-human animals capable of producing heterologous antibodies
7056509 Antibody methods for selectively inhibiting VEGF
7067109 Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids
7084260 High affinity human antibodies and human antibodies against human antigens
7387776 Human monoclonal antibodies against CD30
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional